By a News Reporter-Staff News Editor at Life Science Weekly — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Adherex Technologies Inc. (Form SC TO-I) was posted on June 30, 2014.
The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).
There were 10 documents filed with this form. The SEC file number is 0001144204-14-040401.
The contact information for this company is PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK NC 27709, (919) 636-4530.
Our editors provided additional information about Form SC TO-I: Tender offer statement by Issuer. Replaces SC 13E-4 as of January 2000.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/1211583/0001144204-14-040401-index.html.
Keywords for this news article include: SEC Filing, Biological Products, Adherex Technologies Inc., (No Diagnostic Substances).
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Read Next
